# SegGuidedNet: Sub-Region-Aware Attention Supervision for Interpretable Brain Tumor Segmentation

Source: [SegGuidedNet: Sub-Region-Aware Attention Supervision for Interpretable Brain Tumor Segmentation](<https://www.sota2.com/research/paper/6a0fe33cf984739ed6739fac>)

Collection index: [llms.txt](<https://www.sota2.com/research/llms.txt>)

Data updated: 2026-05-23T05:00:11.413Z

Authors: Hasaan Maqsood, Saif Ur Rehman Khan, Sebastian Vollmer, Andreas Dengel, Muhammad Nabeel Asim

Published: 2026-05-21T14:50:04.000Z

## Abstract

Accurate segmentation of brain tumour sub-regions from multi-parametric MRI is critical for treatment planning yet remains challenging due to morphological variability, class imbalance, and overlapping appearances of tumour regions across imaging sequences. We propose SegGuidedNet, a three-dimensional residual encoder--decoder network introducing a novel SegAttentionGate module that explicitly supervises the decoder to produce spatially discriminative attention maps for each tumour sub-region necrotic core, peritumoral oedema, and enhancing tumour via a lightweight auxiliary loss, adding less than 0.2% parameter overhead. This sub-region supervision maintains decoder discriminability between visually ambiguous classes while providing free-of-cost spatial interpretability at inference without any post-hoc explanation method. Evaluated independently on BraTS2021 and BraTS2023 GLI across 251 held-out subjects each, SegGuidedNet achieves mean Dice of 0.905 (ET= 0.873, TC=0.906, WT=0.935) and 0.897 (ET=0.859, TC=0.902, WT=0.931) respectively, surpassing ensemble-based nnU-Net and HNF-Netv2 as a single model and approaching Swin UNETR a 10-model ensemble within 2--4 Dice points at a fraction of the inference cost. The consistency of results across two benchmark editions further confirms the generalisability of the proposed approach, offering competitive accuracy with built-in interpretability in a lightweight, clinically practical framework.

## Recorded benchmark results

A research result applies to its stated dataset, split, metric and evaluation configuration. Compare like-for-like settings, preserve the metric's unit and direction, and distinguish paper-reported results from independent reproduction. The best result recorded here is not a claim of exhaustive, current global coverage.

- [Brain Tumor Segmentation on BraTS GLI 2023 (test)](<https://www.sota2.com/research/sota/brain-tumor-segmentation-on-brats-gli-2023-test.md>): Brain Tumor Segmentation; BraTS GLI 2023 (test); ET Score: 85.9.

## Original sources and implementation

[Original paper](<https://arxiv.org/abs/2605.22572>)

[PDF](<https://arxiv.org/pdf/2605.22572.pdf>)
